TY - JOUR T1 - Impact of Metabolic Parameters of <sup>18</sup>F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma JF - Anticancer Research JO - Anticancer Res SP - 971 LP - 977 DO - 10.21873/anticanres.13201 VL - 39 IS - 2 AU - NORIFUMI HARIMOTO AU - KOUKI HOSHINO AU - RYO MURANUSHI AU - KEI HAGIWARA AU - TAKAHIRO YAMANAKA AU - NORIHIRO ISHII AU - MARIKO TSUKAGOSHI AU - TAKAMICHI IGARASHI AU - HIROSHI TANAKA AU - AKIRA WATANABE AU - NORIO KUBO AU - KENICHIROU ARAKI AU - HIROYASU TOMONAGA AU - TETSUYA HIGUCHI AU - YOSHITO TSUSHIMA AU - KEN SHIRABE Y1 - 2019/02/01 UR - http://ar.iiarjournals.org/content/39/2/971.abstract N2 - Background: The aim of this study was to identify the prognostic impact of metabolic parameters of 18F-fluorodeoxyglucose (FDG) positron-emission tomography (PET) in patients with intrahepatic cholangiocarcinoma (IHCC) undergoing hepatic resection. Patients and Methods: Twenty-four patients with IHCC who underwent surgical resection were enrolled and 18F-FDG PET parameters maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were measured, as well as overall and recurrence-free survival. Results: High TLG was significantly associated with large tumor size and high carbohydrate antigen 19-9 level. Patients with high SUVmax, high MTV or high TLG had a significantly worse prognosis regarding both overall and recurrence-free survival than those with low SUVmax, low MTV and low TLG, respectively. Multivariate Cox proportional hazards analysis identified that high TLG significantly influenced both overall and recurrence-free survival. Conclusion: Preoperative assessment of TLG by 18F-FDG PET might be a useful prognostic predictor after hepatic resection in patients with IHCC. ER -